Blend Labs, Inc. (NYSE:BLND) Receives $4.80 Consensus PT from Analysts

Shares of Blend Labs, Inc. (NYSE:BLND) have been given a consensus rating of “Hold” by the seven analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $4.1333.

BLND has been the subject of a number of analyst reports. UBS Group reduced their price objective on shares of Blend Labs from $3.00 to $2.00 and set a “neutral” rating for the company in a report on Wednesday. Citizens Jmp dropped their price target on shares of Blend Labs from $7.00 to $5.00 and set a “market outperform” rating for the company in a research report on Wednesday. Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a research note on Sunday, November 16th. Wells Fargo & Company lowered their price objective on Blend Labs from $5.00 to $4.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Blend Labs in a report on Wednesday, January 21st.

Key Blend Labs News

Here are the key news stories impacting Blend Labs this week:

• Positive Sentiment: Some sell‑side firms kept bullish ratings despite cuts to targets — Wells Fargo remains “overweight” (PT lowered to $4) and Citizens JMP keeps “market outperform” (PT lowered to $5), signaling conviction that shares can rebound if fundamentals improve. Benzinga Coverage
• Neutral Sentiment: Intraday price action has tracked broader NYSE Composite moves — market‑wide gains/losses are a material driver of BLND’s short‑term volatility rather than company‑specific news alone. Kalkine: Stock Moves Mirror NYSE Composite
• Neutral Sentiment: Analysts’ views are mixed overall — coverage notes both upside potential and risks, leaving near‑term sentiment fragmented and volume elevated as investors reprice expectations. Globe and Mail: Analysts’ Opinions Are Mixed
• Negative Sentiment: Q4 EPS missed expectations: Blend reported ($0.03) vs. consensus $0.01, which is driving immediate downside despite revenue slightly beating estimates ($32.37M vs. $31.78M). The EPS miss is the primary company‑specific catalyst for the pullback. MarketBeat: Q4 Results & Call
• Negative Sentiment: Analysts cut forecasts and targets after the Q4 release — several firms lowered estimates, increasing the risk of further downward revisions if guidance/metrics don’t improve. Benzinga: Analysts Slash Forecasts
• Negative Sentiment: UBS moved BLND to “neutral” and cut its price target to $2, reflecting a more cautious view that removes a prior upside driver and contributes to share weakness. Benzinga Coverage

Blend Labs Trading Down 12.4%

Shares of NYSE BLND opened at $1.60 on Tuesday. The firm has a market capitalization of $414.30 million, a price-to-earnings ratio of -15.95 and a beta of 1.27. Blend Labs has a one year low of $1.57 and a one year high of $4.49. The business has a fifty day simple moving average of $2.28 and a 200 day simple moving average of $3.00.

Blend Labs (NYSE:BLND) last posted its quarterly earnings results on Tuesday, March 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.04). The business had revenue of $32.37 million for the quarter, compared to analysts’ expectations of $31.78 million. On average, research analysts anticipate that Blend Labs will post -0.19 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Blend Labs news, insider Brian Kneafsey sold 25,000 shares of the company’s stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $3.06, for a total value of $76,500.00. Following the sale, the insider directly owned 649,824 shares in the company, valued at $1,988,461.44. This represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders sold 33,125 shares of company stock valued at $93,169 in the last quarter. Corporate insiders own 35.52% of the company’s stock.

Institutional Investors Weigh In On Blend Labs

Several institutional investors and hedge funds have recently made changes to their positions in the company. Irenic Capital Management LP bought a new position in shares of Blend Labs in the fourth quarter valued at approximately $9,469,000. Park West Asset Management LLC bought a new stake in Blend Labs during the 3rd quarter worth approximately $6,205,000. Potrero Capital Research LLC acquired a new stake in Blend Labs during the 4th quarter valued at $5,050,000. Marshall Wace LLP raised its position in Blend Labs by 157.6% in the 2nd quarter. Marshall Wace LLP now owns 2,522,141 shares of the company’s stock valued at $8,323,000 after purchasing an additional 1,543,220 shares during the last quarter. Finally, Prospect Capital Advisors LLC raised its position in Blend Labs by 338.2% in the 3rd quarter. Prospect Capital Advisors LLC now owns 1,820,150 shares of the company’s stock valued at $6,644,000 after purchasing an additional 1,404,750 shares during the last quarter. Institutional investors and hedge funds own 52.56% of the company’s stock.

Blend Labs Company Profile

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.